Altaris has sold Penlon to BPL Medical Technologies
Altaris Capital Partners, LLC (“Altaris”) has sold Penlon Ltd. (“Penlon” or the “Company”) to Goldman Sachs backed BPL Medical Technologies Private Ltd.
Headquartered in Abingdon, U.K., Penlon is a leading global manufacturer of anaesthesia systems and vaporizers with worldwide distribution networks. Penlon’s product range complements BPL Medical’s existing portfolio and will help in expanding its presence in the critical care segment. Penlon will continue to be based and operated from the U.K. under the leadership of the existing management team.
Penlon is an internationally recognized brand in the critical care segment with a footprint in 96 countries, including India. With a strong focus on product innovation and a leading position in developed and emerging markets, the Company designs, engineers and manufactures anaesthesia systems, vaporizers and other complementary products. These products are sourced by hospitals, pharmaceutical companies and anaesthesia system manufacturers worldwide. Penlon has a reputation for exceptional product quality and prompt after-sales support and services.
BPL Medical is one of the largest Indian medical devices companies with over 300 personnel and a large distributor network located across India. In August of 2013, Goldman Sachs invested in BPL Medical to fund the expansion of its medical devices business. This latest acquisition will increase BPL Medical’s presence and distribution in other emerging and developed markets.
Sunil Khurana, Chief Executive Officer of BPL Medical, said, “This acquisition will help us penetrate the large critical care segment in India with Penlon’s world-renowned technology-driven anaesthesia machines and vaporizers. BPL Medical will leverage Penlon’s R&D capabilities to develop many new products suitable for India and other emerging markets. Additionally, Penlon’s global reach will help expand BPL Medical’s international presence.”
Stephen Moon, Chief Executive Officer of Penlon, said, “This partnership secures a long-term investment which underpins our product strategy to develop world-class anaesthesia machines, monitors and next-generation vaporizers over the coming years. We now plan to expand our product development capabilities across the business and will bring forward a number of key projects. We will also benefit from BPL Medical’s strength in India, which will provide substantial growth in the years to come.”
Lincoln International acted as the exclusive financial advisor to Altaris and Penlon, working closely with the Company’s owners and management team throughout the sale process. This included providing advisory expertise and managing the preparatory, marketing, negotiation and due diligence phases of the transaction.
Penlon is a long-established medical device company, based near Oxford in the U.K. Founded in 1943, and a four-time winner of the Queen’s Award for Enterprise, Penlon designs, manufactures and sells products and services into 96 countries, spanning Europe, North and South America, the Middle East and Asia. Penlon’s key areas of business are: anaesthesia, vaporizers, laryngoscopes, suction and oxygen therapy, OEM and technical service. It provides products and services both directly to hospitals and clinics, and indirectly through a network of distributors. Penlon also manufactures and sells OEM products to other global anaesthesia manufacturers. For further information, please visit www.penlon.com.
About Altaris Capital Partners, LLC
Altaris Capital Partners, LLC is an investment firm focused exclusively on the healthcare industry. Managing $1.3 billion of equity capital, Altaris invests in businesses that meet clearly defined healthcare needs and leverages its extensive industry knowledge and relationships to accelerate growth and value appreciation. Altaris is based in New York, New York. For further information, please visit www.altariscap.com.
About BPL Medical Technologies
BPL Group has served the medical fraternity for over five decades. Since 1967, BPL Medical’s high standards of product performance have made it the supplier of choice for hospitals, clinics and practicing physicians across India. BPL is widely trusted for its reliable products and dependable service to its customers. BPL Medical’s range of products includes electrocardiographs, patient monitors, defibrillators, central nursing stations, stress test systems, oxygen concentrators, ultrasound scanners, colposcopes, foetal monitors, foetal dopplers, syringe/volumetric pumps, C-arms and X-rays. The products are manufactured in an ISO 13485 certified facility and conform to global standards of quality assurance and best practice. BPL Medical’s collaboration with the best brands across the world and high-quality manufacturing facilities provides customers with the latest technology in healthcare at affordable prices. For further information, please visit www.bplmedicaltechnologies.com.
Meet Our Professionals
View More Transactions
Lincoln International is pleased to announce the successful sale of C³ (Cannabinoid Compound Company), a subsidiary of Bionorica SE, a producer and marketer of cannabis-based therapeutic compounds, to Canopy Growth
Lincoln is pleased to announce that it has advised Riello Investimenti SGR on the sale of Trafimet Group to Kemppi Oy
Lincoln International is pleased to have advised Tikehau Capital on its £23 million minority investment into Medtrade, a UK based manufacturer of advanced woundcare and consumer healthcare products
Lincoln International is pleased to announce the successful completion of a $20 million Series C financing round for Rapid Medical